A Parents Guide to Kid’s Face Coverings, Plus 28 to Shop
Plus, how to entice your little one to wear themSo, with adults all over the country getting used to this new way of life, what does that mean for our kids? Turns out it’s not that simple explaining the ins and outs of, err, a global pandemic you didn’t really see coming to your children.
Gallery: 11 (sometimes) deadly diseases that hopped across species (Live Science)
-
11 (sometimes) deadly diseases that hopped across species
Bacteria and viruses that are deadly to one type of creature can evolve quickly to infect another. While the new coronavirus SARS-CoV-2 (which causes COVID-19) is the latest example, a host of infectious and deadly diseases have hopped from animals to humans and even from humans to animals.
Children with a runny nose DON'T have Covid-19, expert warns
Professor Tim Spector, from King's College London, said that a runny nose, congestion and sneezing were a 'sure' sign a child was suffering from the common cold and not coronavirus.Professor Tim Spector, of King's College London, moved to reassure parents the symptom, alongside congestion and sneezing, is a 'sure sign' they have a cold and not Covid-19.
The cross-species infection can originate on farms or markets, where conditions foster mixing of pathogens, giving them opportunities to swap genes and gear up to infect (and sometimes kill) previously foreign hosts. Or the transfer can occur from such seemingly benign activities as letting a performance monkey on some Indonesian street corner climb on your head. Microbes of two varieties can even gather in your gut, do some viral dancing, and evolve to morph you into a contagious host.
Diseases passed from animals to humans are called zoonoses. There are more than three dozen we can catch directly through touch and more than four dozen that result from bites. But disease-carrying parasites are not picky about hosts. Human diseases can decimate animal populations, too, from such well-meaning activities as ecotourism.
Covid-19 vaccines must be compared to ensure 'most effective are used'
Writing in the prestigious Lancet Infectious Diseases journal, they said comparisons should be 'standardised' to consider factors including the ability to supply the vaccine quickly.Researchers said it is unlikely 'we will see a single vaccine winner in the race against Covid-19'.
-
Novel coronavirus
The novel coronavirus that causes the disease COVID-19 was first identified at the end of December 2019 in Wuhan, China, where officials suspect the source was somehow linked to a seafood market there. Genetic analyses of the virus suggest it originated in bats. However, because no bats were sold at the seafood market at the outbreak's epicenter, scientists think an as-yet-unidentified animal acted as a go-between in transmitting the coronavirus to humans. This "intermediate" animal could be the pangolin, an endangered, ant-eating mammal, according to a handful of studies of the virus. Even so, the viruses that have been found in samples taken from illegally trafficked pangolins don't match the SARS-CoV-2 virus closely enough to prove the pangolin as this stepping stone, the journal Nature reported.
A previous study had pointed to snakes — which were sold at that seafood market — as the possible source of SARS-CoV-2. Even so, experts criticized the analysis that led to that conclusion, saying it's still unclear if coronaviruses can even infect snakes.
Containers at Danish mink farms are overflowing with dead animals
A potential vaccine has proven effective in early animal trials against the mutated strain of Covid from mink, Danish students have revealed, as the cull of millions of animals continues.So far, more than 200 people have been infected with the mutated coronavirus which originated in Denmark, and authorities are desperately trying to dispose of the potentially dangerous animals.
-
Influenza pandemics
The 1918 influenza pandemic swept the world within months, killing an estimated 50 million people — more than any other illness in recorded history for the short time frame involved. The H1N1 influenza virus that infected more than one-third of the globe had an avian origin. First identified in the United States by military personnel in the spring of 1918, the virus killed an estimated 675,000 Americans, according to the Centers for Disease Control and Prevention (CDC).
Unlike some flu strains that mainly kill the elderly and those with compromised immune systems, the 1918 strain hit young adults hardest, as the older population seemed to have some immunity built up from a past H1N1 virus. In one year, the average life expectancy in the United States dropped by 12 years.
Another H1N1 virus, this one called (H1N1)pdm09 cropped up in the spring of 2009 and lasted until the next spring, with the CDC estimating some 60.8 million cases and 12,469 deaths in the U.S. Worldwide, the virus killed between 151,700 and 575,400 individuals, the CDC estimates. That virus appears to have originated in pig herds, with a so-called reassortment of influenza viruses — when the viruses swap genetic information — occurring naturally in North American and Eurasian pig herds.
No, soaring COVID-19 cases are not due to more testing
COVID-19 cases are surging upward around the U.S., reaching 100,000 daily cases for the first time on Nov. 4 and 150,000 only eight days later. Some believe this increase in reported is a result of increases in testing, as more than 1.5 million tests are performed every day in the U.S. But the evidence is clear that these high numbers reflect a true increase in the number of COVID-19 infections. © Provided by Live Science EMS workers pick up a suspected COVID-19 patient in the Rio Grande Historic District of El Paso, Texas, on Nov. 15, 2020. Hospitalizations, deaths and test-positivity rates are going up.
-
Bubonic plague
Nothing beats the 14th-century Black Death (also called Bubonic Plague) for sheer global impact of a single disease outbreak and bringing civilization to its knees. It is the epitome of plague. Corpses piled in the streets from Europe to Egypt and across Asia. Some 75 million people died — at a time when there were only about 360 million living on Earth. Death came in a matter of days, and it was excruciatingly painful.
Plague is a bacterial disease caused by Yersinia pestis. It is carried by rodents and even cats, and hops to humans through bites from infected fleas (often rat fleas). The disease becomes most deadly to us when transmitted between people, as became the case in the 1300s. Symptoms include fever, chills, weakness, and swollen and painful lymph nodes. Even today, if not treated, the disease is deadly.
The plague of the 14th-century resulted after the rare bacteria had been dormant for centuries in Asia's Gobi Desert. After awaking in the 1320s, it piggybacked along trade routes from China, through the rest of Asia and eventually to Italy in 1347, then later to Russia.
It took centuries for some societies to recover, as some of the survivors mistrusted local authorities and in some cases even God, under whose wrath they presumably had suffered.
PROF BRENDAN WREN: There is nothing to fear from the Covid vaccine
PROF BRENDAN WREN: Once an immunisation programme is fully under way early next year, society really can begin to return to normal, thanks to the work of scientists across the globe.But Christmas has arrived early. After months of locked-down misery, the best gift we could have is the news that scientists have developed several effective anti-Covid vaccines.
-
New Car Gadget Magically Removes Scratches & Dents
Ad NanoMagic
Diseases that bite
A range of zoonotic diseases are caused by animal bites. And mosquitoes lead the way: Malaria, which is caused by a parasite and gets transmitted to humans through bites from infected mosquitoes, infected an estimated 228 million people across the globe in 2018, with 405,000 related deaths that year, most of which were in kids in Africa, according to the CDC.
Mosquito-borne dengue fever infects some 400 million people annually, with about 100 million of those individuals getting sick from the infection and 22,000 dying from it, the CDC reports. That disease is transmitted through bites from infected mosquitoes in the Aedes genus.
-
From pets and mice
Illustrating our illness connection to animals and especially pets, Rabies kills about 55,000 people globally each year, mostly in Asia and Africa. In the U.S., only one or two people a year die from Rabies, the CDC says. Most deaths follow a bite from an infected pet dog, though wild animals can carry rabies, too.
You don't even have to be bitten by animals to get some deadly diseases from them. Hantaviruses are carried mostly by rodents and get transmitted to humans when viral particles that are shed in urine, feces and saliva get aerosolized … and you breathe in that dust. The CDC considers the Sin Nombre virus as the most important hantavirus in the U.S. that can cause the disease hantavirus pulmonary syndrome (HPS). That hantavirus is spread by deer mice. In the U.S., however, no person-to-person transmission of this virus has been reported to date, the CDC says. Symptoms include fever, chills, myalgia, headache and gastrointestinal issues, among other features. And although this disease is rare, the fatality rate is 36%, according to a 2015 CDC report. Since it was first identified in 1993, more than 600 cases in the U.S. have been confirmed, according to the CDC.
GMB's Kate Garraway reflects on "missed moments" amid husband Derek's battle with coronavirus
"It really does break your heart thinking about it."Good Morning Britain presenter Kate Garraway has reflected on the moments her family has missed this year amid her husband Derek Draper's COVID-19 battle.
-
HIV/AIDS
HIV, the virus that causes AIDS, has been traced to a type of chimpanzee in Central Africa, according to the CDC. The chimp version of this disease (simian immunodeficiency virus, or SIV) was likely passed to humans when they hunted these animals for meat, getting exposed to their infected blood. Once they were exposed, the virus mutated into HIV. Studies suggest the virus may have jumped to humans as far back as the 1800s, the CDC reports.
HIV destroys the immune system, opening the door to a host of deadly infections or cancers. For example, Tuberculosis (TB) kills nearly a quarter of a million people living with HIV each year.
In 2018, 770, 000 people died from causes related to HIV, and 1.7 million people were infected with the virus that year. At the end of 2018, 37.9 million people were living with HIV, according to the WHO. Two-thirds of HIV infections are in certain countries in Africa.
HIV can be spread between people through an exchange of bodily fluids (from an infected person), including blood, breast milk, semen and vaginal secretions. Mothers can pass the virus to their newborns during delivery as well, the WHO says.
-
Mind control
The bizarre parasite Toxoplasma gondii may infect the brains of about 2 billion people worldwide, including about 40 million Americans. Some studies have suggested the parasite may contribute to schizophrenia.
However, its primary hosts are house cats, in which the microbe reproduces sexually inside the feline's gut. Cats left to roam are more prone to picking it up. You can get it from cat feces. The bug is also found in many other mammals, too (where it reproduces asexually). The parasite eggs then get carried inside a cat's feces, where humans can pick them up when infected poop gets aerosolized (as it would during litter-scooping).
NHS data suggests English hospitals are STILL less full than last year
Statistics from NHS England show that 89 per cent of hospital beds had patients in them, on average, in the second week of December, which was down from 94.9 per cent this time last year.Despite the health service having more breathing room than 12 months ago, Boris Johnson today refused to rule out another national shutdown as he warned the country was struggling to get a grip on the winter wave of infections.
Once T. gondii enters its human host, it hides out in body areas lacking immune defense, and these include the brain, heart and skeletal muscle tissue, Live Science previously reported. Once cozy in one of those areas, the encapsulated eggs transform into an active form of the parasite called a tachyzoite, which can multiply and spread.
T. gondii is sometimes called a "mind control" parasite because rodents infected with it seem to forget their fear of cats and in turn be drawn to the smell of cat urine. That makes them easy prey for cats and an easy route of transmission for T. gondii.
Most humans infected with the parasite will have no noticeable symptoms, according to the CDC. In about 10% to 20% of cases, mild symptoms show up and these include flu-like aches and swollen lymph nodes that can last for weeks to months. Severe reactions are rare but can cause serious problems, from vision loss to brain damage.
-
Cysticercosis
People can get cysticercosis after swallowing water or food containing the eggs of the parasitic tapeworm called Taenia solium. These larvae then creep into muscle and brain tissues, where they form cysts. Humans can also pick up the parasite if they eat raw or undercooked pork containing these cysts, which then attach to the lining of the small intestine; over about two months, those cysts develop into adult tapeworms.
The most dangerous form of the disease occurs when the cysts enter the brain, called neurocysticercosis. Symptoms can include headaches, seizures, confusion, brain swelling, difficulty balancing and even stroke and death, according to the CDC. About 1,000 cases are reported in the U.S. each year, according to the National Organization for Rare Disorders.
-
Ebola
Ebola virus disease, which is caused by one of five strains of the Ebola virus, is a widespread threat to gorillas and chimps in Central Africa. The disease may have spread to humans from infected bats or infected non-human primates, the CDC says. It was first identified in 1976 near the Ebola River in what is now called the Democratic Republic of the Congo. People can catch four strains of the virus through contact with infected blood or bodily fluids from an animal carrying the virus. That person can then spread the virus to others through close contact.
The awful symptoms include: sudden onset of fever, intense weakness, muscle pain, headache and sore throat, often followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding.
The average fatality rate for this virus is 50% though it has varied from 25% to 90% in different situations, the WHO reports.
-
20+ Ingenious Inventions From 2020
Ad GadgetTechStore
Lyme disease
Nobody likes to find a tick head-first on their body, lapping up a juicy blood meal. But even worse than the ick factor is the disease that some ticks carry and can transmit during their gorging. Black-legged ticks can transmit bacteria that cause Lyme disease to humans. The disease is typically caused by Borrelia burgdorferi, though sometimes another Borrelia species, called B. mayonii is the culprit, according to the CDC.
Symptoms typically include fever, headache, tiredness and a distinct ring-like skin rash called erythema migrans. If Lyme's is left untreated, it can spread to a person's joints, t heir heart and even their nervous system, the CDC notes. But when caught early enough, a few weeks of antibiotics can successfully get rid of the bacteria, the CDC says.
Every year, about 30,000 cases of Lyme disease are reported from state health departments to the CDC. Using other methods, the CDC estimates about 300,000 people in the U.S. may get the disease every year.
-
Humans infect chimps and gorillas
Humans can deliver pathogens to our animal brethren as well. For instance, scientists have speculated that chimps at Gombe Stream National Park in Tanzania contracted polio from humans, according to Fabian Leendertz, a wildlife epidemiologist at the Robert Koch-Institute and Max Planck Institute for Evolutionary Anthropology in Germany.
Gorillas and chimpanzees in West Africa have been killed by outbreaks of anthrax (caused by the bacterium Bacillus anthracis), which might have originated from cattle herded by humans, although Leendertz said these events may have been caused by anthrax existing naturally in the forests.
In 2009, exposure to humans may have led to an outbreak of the respiratory disease human metapneumovirus infection in captive chimpanzees at Lincoln Park Zoo in Chicago. A 9-year-old male chimp named Kipper died from the infection, the Chicago Tribune reported at the time.
-
-
With several coronavirus vaccines barreling through late-stage trials, adults could receive an approved vaccine in months. But even then, we likely won't know whether any of these vaccines work in children.
© Provided by Live Science child receiving vaccine Only a handful of coronavirus vaccine trials currently include children as participants — an Oxford-AstraZeneca trial being one of them, Stat News reported. The Chinese company Sinovac Biotech will include children ages 3 to 17 in an upcoming trial, according to ClinicalTrials.gov, but by and large, most vaccine developers have not launched similar trials with participants younger than age 18. And in the U.S., no children have been enrolled in coronavirus vaccine trials, The New York Times reported.
Vaccines typically get tested in adults before children to allow their safety profiles to be fully assessed, and their potential risks minimized, before they're given to kids. In the case of COVID-19, children generally face a far lower risk of hospitalization and death compared with adults, so taking an untested vaccine could pose higher risks than the virus itself. That said, with data from large adult trials now rolling in, some experts have argued that vaccine trials for kids should start sooner, rather than later.
Related: Here are the most promising coronavirus vaccine candidates out there
"The sooner, the better," said Dr. Flor Munoz-Rivas, an associate professor of pediatric infectious disease at the Baylor College of Medicine in Houston. Given early data gathered in late-stage adult trials, which include thousands of participants, vaccine developers could launch trials for older children ages 12 to 17, she said. If a vaccine appears safe and effective in this group, the trials could then continue in younger and younger children.
In a commentary, published Sep. 18 in the journal Clinical Infectious Diseases, Munoz-Rivas and her colleagues argue that coronavirus vaccine trials for children "should begin now." To delay such trials could mean delaying "our recovery from COVID-19 and unnecessarily prolong[ing] its impact upon children's education, health and emotional well-being," they wrote.
The sooner, the better?
Even though adult hospitalization rates for COVID-19 far outpace those for children, that doesn't mean kids aren't being adversely impacted by the disease. The child hospitalization rates for COVID-19 are comparable to those for diseases like chickenpox, Hepatitis A and rotavirus, before vaccines for those infections became widely utilized, the commentary notes.
In addition, about one-third of kids who are hospitalized with COVID-19 end up in intensive care, the authors add. And some infected children develop a condition known as multisystem inflammatory syndrome in children (MIS-C), in which severe inflammation throughout the body causes skin rashes, high fever and abdominal pain, among other symptoms, Live Science previously reported. In a recent study of MIS-C associated with COVID-19, published in The New England Journal of Medicine, 80% of affected children were admitted to the ICU.
As of early September, more than 100 children had died from COVID-19 in the U.S., the authors noted. That's compared with 188 children who died during the 2019-2020 flu season, according to the Centers for Disease Control and Prevention. "Right now, [both diseases] seem to be similar in terms of mortality, but of course, flu is around for a limited period of time, while COVID circulation is ongoing and we don’t know how long it will last," Munoz-Rivas said. "The potential for surpassing flu is there, in my opinion."
Related: 20 of the worst epidemics and pandemics in history
An approved vaccine would not only guard children against potential disease and death, but also reduce the spread of COVID-19 from children to others and allow schools to safely resume with fewer distancing measures in place, Dr. Steven Joffe, a bioethics and pediatrics professor at the University of Pennsylvania Perelman School of Medicine, wrote in a commentary in The Washington Post.
"They can definitely transmit the infection, especially older children," Munoz-Rivas noted.
It's still unclear how often children below age 10 catch and spread COVID-19, but in a Morbidity and Mortality Weekly Report, published Sep. 28, researchers describe how older teens may be as likely as adults to transmit the virus. Without an approved vaccine for those under age 18, the effort to curb viral spread from children will remain dependent on other countermeasures, like social distancing and mask wearing, Joffe wrote.
Trials for children
Once trials for children get off the ground, enrolling participants may take longer than it would for adult vaccines, Munoz-Rivas noted. COVID-19 vaccine trials for adults have enrolled thousands to tens of thousands of participants in a matter of months, but "the pace of doing a pediatric study is not usually that fast," she said. For a child to participate in a trial, their legal guardian must give consent on their behalf, and children ages 7 and older must themselves also agree to participate after receiving a thorough explanation of the study's requirements and risks, she said.
Even with this involved enrollment process, during the 2009 H1N1 pandemic, "we did very quickly go from adults to children, and down to different age groups," Munoz-Rivas said. In one trial, "we enrolled hundreds of kids in two weeks." Initial trials of COVID-19 vaccines in kids would likely enroll a few hundred participants, she said.
Typically, after trials in 12- to 17-year-olds, vaccine developers move on to 5- to 12-year-olds, then to children younger than age 5. "It's not going to be likely that very young infants will be part of the studies early on," Munoz-Rivas said.
Just like adult trials, trials with children aim to find the safest and most protective dose for a given vaccine, but data already gathered in adults can hint at what dose might be best. Children in early trials receive smaller doses than adult participants, and if they have no harmful side effects, trial leaders gradually increase this dosage. At the same time, trial leaders monitor the amount of antibodies children produce at each given dose; thanks to their young immune systems, children may not need as high a dose as adults to prompt a strong immune response, Munoz-Rivas said.
Related: 5 dangerous myths about vaccines
That said, this initial immune protection might wear off over time, as studies hint that immunity to seasonal coronaviruses may be short-lived, Live Science previously reported. Immunity to COVID-19, whether gained through natural infection or a vaccine, may similarly wane through time.
So after receiving an initial COVID-19 vaccine, both children and adults may require booster shots sometime in the future, Munoz-Rivas noted. Similarly, older children get boosters for chicken pox and whooping cough after receiving their initial doses in infancy. If possible, both child and adult participants in COVID-19 trials should be monitored after their vaccination, for up to 10 years or so, to determine when and whether a booster is necessary, Munoz-Rivas said. The timing and dosage of these boosters may differ between adults and children, depending on their initial immune responses to the vaccine, she added.
As in adult trials, vaccine developers must be on the lookout for both short- and long-term side effects that emerge in vaccinated children. Mild side effects might include mild fever, muscle aches or soreness at the injection site, as have been noted in adults, while a severe reaction might include severe inflammation or an overblown immune response.
Since vaccines trigger the production of antibodies that target the coronavirus, vaccine developers need to ensure that this immune response is strong enough to be protective, but so strong that it's harmful to the child.
For instance, while the exact cause of MIS-C is unknown, one recent study found that children with the condition have high concentrations of specific antibodies in their blood; these antibodies grab onto part of the virus called the "receptor binding domain" (RBD), a prime target for vaccines. The new study did not show whether these antibodies actually cause MIS-C — they may only be a sign of the illness — but in a commentary accompanying the report, experts cautioned vaccine developers to watch for any symptoms of MIS-C in vaccinated children. The worry would be that a vaccine could prompt production of specific RBD antibodies and that would somehow drive the onset of MIS-C, but this is highly theoretical and may not prove to be a risk at all, Munoz-Rivas noted.
"The issue is, 'How well do we understand the mechanism'" of how MIS-C occurs, Munoz-Rivas said. "It's not necessarily an antibody issue," and most likely, an effective vaccine would help protect children from MIS-C by protecting them from catching COVID-19 in the first place, she said. Given the direct benefits to children, and indirect benefits to those they interact with, pediatric trials of COVID-19 vaccines should start as soon as possible, she and her co-authors wrote.
"For children, a vaccine has the added benefit of returning them safely to school and extracurricular activities, and allowing them to engage with their world face-to-face once again," they wrote. "Ensuring acceleration of vaccine clinical trials to warp speed for children will be critical in making this our future reality."
Originally published on Live Science.
NHS data suggests English hospitals are STILL less full than last year .
Statistics from NHS England show that 89 per cent of hospital beds had patients in them, on average, in the second week of December, which was down from 94.9 per cent this time last year.Despite the health service having more breathing room than 12 months ago, Boris Johnson today refused to rule out another national shutdown as he warned the country was struggling to get a grip on the winter wave of infections.